On these bases, in the context of a search for new DMLs as potential antidiabetic agents, we selected as targets aldose reductase (AR) and protein tyrosine phosphatase 1B (PTP1B), two enzymes differently involved in the development of DM and its complications. Here, PTPN1 is linked to diabetes mellitus.